Literature DB >> 7356828

Clinical characteristics distinguishing hereditary from sporadic medullary thyroid carcinoma. Treatment implications.

M A Block, C E Jackson, K A Greenawald, J B Yott, A H Tashjian.   

Abstract

Distinctive differences between the hereditary and sporadic varieties of medullary thyroid carcinoma include the uniform bilaterality, consistent association of C cell hyperplasia, and the frequent association with other endocrine lesions as characteristics of the hereditary type. Total thyroidectomy is required for hereditary medullary thyroid carcinoma. Lateral cervical lymph node dissections do not appear necessary for the hereditary type when not palpable, detected only by family screening, and when biopsy of midjugular lymph nodes shows no evidence of metastasis. For palpable medullary thyroid carcinoma, the eradication of all cervical locations is unlikely to result in normal or undetectable levels of serum calcitonin postoperatively, even though such appears more likely for the sporadic variety.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7356828     DOI: 10.1001/archsurg.1980.01380020012004

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  16 in total

1.  Extended RET gene analysis in patients with apparently sporadic medullary thyroid cancer: clinical benefits and cost.

Authors:  Susan C Lindsey; Ilda S Kunii; Fausto Germano-Neto; Misaki Y Sittoni; Cléber P Camacho; Flávia O F Valente; Ji H Yang; Priscila S Signorini; Rosana Delcelo; Janete M Cerutti; Rui M B Maciel; Magnus R Dias-da-Silva
Journal:  Horm Cancer       Date:  2012-05-31       Impact factor: 3.869

2.  Prognostic factors for sporadic medullary thyroid carcinoma.

Authors:  Kaptan Gülben; Uğur Berberoğlu; Mustafa Boyabatli
Journal:  World J Surg       Date:  2006-01       Impact factor: 3.352

3.  Long-term outcome of reoperations for medullary thyroid carcinoma.

Authors:  Elizabeth Fialkowski; Mary DeBenedetti; Jeffrey Moley
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

4.  Ultrastructural study of poorly differentiated medullary carcinoma of the thyroid.

Authors:  K Kakudo; A Miyauchi; S Katayama; K Watanabe
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

5.  Linkage analysis of hereditary thyroid carcinoma with and without pheochromocytoma.

Authors:  S A Narod; H Sobol; Y Nakamura; C Calmettes; J L Baulieu; J C Bigorgne; G Chabrier; J Couette; J L de Gennes; J Duprey
Journal:  Hum Genet       Date:  1989-11       Impact factor: 4.132

6.  Screening for familial medullary thyroid carcinoma: a review.

Authors:  B A Ponder
Journal:  J R Soc Med       Date:  1984-07       Impact factor: 5.344

7.  Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection.

Authors:  J F Moley; M K DeBenedetti
Journal:  Ann Surg       Date:  1999-06       Impact factor: 12.969

8.  Improved results of cervical reoperation for medullary thyroid carcinoma.

Authors:  J F Moley; W G Dilley; M K DeBenedetti
Journal:  Ann Surg       Date:  1997-06       Impact factor: 12.969

9.  Relationship of CD15 immunoreactivity and prognosis in sporadic medullary thyroid carcinoma.

Authors:  N Neuhold; F Längle; M Gnant; U Hollenstein; B Niederle
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

10.  Chromosome 20 deletion in human multiple endocrine neoplasia types 2A and 2B: a double-blind study.

Authors:  V R Babu; D L Van Dyke; C E Jackson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.